- Report
- October 2023
- 199 Pages
Global
From €4808EUR$4,950USD£4,147GBP
- Report
- March 2024
- 192 Pages
Global
From €3277EUR$3,374USD£2,827GBP
€3641EUR$3,749USD£3,141GBP
- Report
- April 2024
- 89 Pages
Global
From €5439EUR$5,600USD£4,692GBP
- Report
- January 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- April 2023
- 110 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- September 2022
- 212 Pages
Global
From €3497EUR$3,600USD£3,016GBP
- Report
- September 2022
- 77 Pages
North America
From €1457EUR$1,500USD£1,257GBP
- Report
- September 2022
- 88 Pages
Asia Pacific
From €1457EUR$1,500USD£1,257GBP
- Report
- September 2022
- 88 Pages
Europe
From €1457EUR$1,500USD£1,257GBP
- Report
- September 2022
- 88 Pages
Middle East, Africa
From €1457EUR$1,500USD£1,257GBP
The Cardiac Safety Service market is a subset of the Cardiovascular Devices market, which focuses on the development and production of medical devices used to diagnose, treat, and monitor cardiovascular diseases. Cardiac Safety Services are designed to assess the safety of drugs and medical devices in clinical trials, as well as to monitor the safety of drugs and medical devices after they have been approved for use. These services include pre-clinical and clinical safety assessments, pharmacovigilance, and post-market surveillance.
Cardiac Safety Services are essential for the development of safe and effective drugs and medical devices, and are used by pharmaceutical and medical device companies, clinical research organizations, and regulatory agencies.
Some companies in the Cardiac Safety Service market include Biotronik, Cardiac Science, CardioComm Solutions, CardioFocus, CardioKinetix, CardioMEMS, CardioVascular Dynamics, and Corindus Vascular Robotics. Show Less Read more